Company intelligence / Profile preview

geneOmbio Technologies

Pune, Maharashtra, India

Ownership: Private
Employees: ~11
Development stage: Other

Overview

geneOmbio Technologies is an ISO 17025:2005 certified biotechnology and pharmaceutical services company specializing in genomics research, contract research services, and laboratory testing. It offers diagnostic reagents, vaccines, and antisera with a core focus on healthcare and medical diagnostics. There is no evidence of clinical-stage therapeutic assets.

Therapeutic areas: OtherInfectious Diseases
Modalities: Diagnostic reagentVaccineAntiseraLaboratory chemical
Industry: Molecular Diagnostics

Partnerships

Various pharma, biopharma, food, and agriculture companies (contract research services over last 15 years)

Beyond the preview

Go deeper on geneOmbio Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on geneOmbio Technologies.

Explore the full profile